Explore the potential of artificial intelligence tools to support medication reviews for patients with multiple chronic conditions in this 27-minute seminar from the Alan Turing Institute. Delve into the DynAIRx project, which aims to develop AI solutions targeting patients at highest risk of medicine-related harm. Examine current medication review practices, discuss barriers and facilitators to AI implementation, and consider how these tools could enhance reviews for individuals with multimorbidity and polypharmacy. Access accompanying slides to supplement the seminar content and gain a comprehensive understanding of this innovative approach to improving patient care through AI-assisted prescribing.